Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)
NCT01546766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 315
Last updated 2023-11-07
Summary
The basic objective of this project is to test a modification of existing technology for monitoring the responses of the pupil to light as a method for detecting regional losses of function of the retina. The "instrument" consists of a commercially available set of goggles that monitor the eye positions and pupils using infrared light and small cameras. The signals from the monitoring cameras are collected in a computer that records how their pupils have responded to each lighting condition. Because diabetics develop damage initially to certain parts of the retina before they have more serious damage, the ultimate goal of this research is to develop a simple, noninvasive, rapid method for widespread screening of diabetics in order to identify those who may require medical attention and/or therapy for diabetic retinopathy.
Conditions
- Diabetes
- Retinal Disorders
Interventions
- DEVICE
-
Pupillometry testing.
Sponsors & Collaborators
-
Neurolign
collaborator INDUSTRY -
Jules Stein Eye Institute
collaborator OTHER -
National Eye Institute (NEI)
collaborator NIH -
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Michael B. Gorin, MD, PhD · Jules Stein Eye Institute, Dept. of Ophthalmology, David Geffen School of Medicine at UCLA
-
Alexander Kiderman, PhD · Neuro Kinetics, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-02-28
- Primary Completion
- 2015-08-31
- Completion
- 2015-08-31
Countries
- United States
Study Locations
More Related Trials
-
Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy
NCT02671864 ·Status: UNKNOWN ·Phase: NA
-
Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
NCT03112005 ·Status: COMPLETED
-
Early Retinal Neurodegeneration As Risk Factor, Biomarker and Pharmacological Target of Diabetic Retinopathy
NCT06582472 ·Status: RECRUITING
-
Predicting the Risk of Diabetic Neurodegenerative Disorders by Artificial Intelligence Tools Based on Retinal Imaging
NCT06541834 ·Status: RECRUITING
-
Long Term Follow-Up of Diabetic Retinopathy
NCT00001395 ·Status: COMPLETED
-
Macular Perfusion Changes After Anti-VEGF Versus Targeted Retinal Photocoagulation in Proliferative Diabetic Retinopathy
NCT04674254 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of EyeArt Performance With Retinal Imaging Devices
NCT04302012 ·Status: COMPLETED
-
Treating Early Stage Diabetic Retinopathy
NCT05132660 ·Status: ENROLLING_BY_INVITATION ·Phase: EARLY_PHASE1
-
Patient Navigator Intervention for Diabetic Retinopathy
NCT05188703 ·Status: COMPLETED ·Phase: NA
-
Photobiomodulation for the Treatment of Diabetic Macular Edema
NCT02457975 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of Dopamine on Diabetic Retinopathy
NCT02706977 ·Status: COMPLETED ·Phase: PHASE1
-
Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 Diabetes
NCT00880139 ·Status: TERMINATED
-
Diabetic Retinopathy Tethered Augmented Reality With Eye4 Study
NCT05491746 ·Status: COMPLETED ·Phase: NA
-
Anti-VEGF Treatment for Prevention of PDR/DME
NCT02634333 ·Status: COMPLETED ·Phase: PHASE3
-
Diabetic Macular Edema and Diabetic Retinopathy Screening (TeleMed) With Automated Retinal Photography
NCT01790945 ·Status: UNKNOWN
-
Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser Treatment
NCT01792141 ·Status: COMPLETED
-
OCT-angiography in Diabetic Patients
NCT02870803 ·Status: UNKNOWN
-
Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients
NCT05608265 ·Status: COMPLETED ·Phase: NA
-
Blood Factors and Diabetic Retinopathy
NCT00005761 ·Status: COMPLETED
-
Investigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy Patients
NCT02621580 ·Status: COMPLETED ·Phase: NA
-
Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa
NCT04925687 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Decision Support Algorithm to Predict Diabetic Retinopathy
NCT03769948 ·Status: UNKNOWN
-
Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
NCT06713720 ·Status: RECRUITING ·Phase: NA
-
Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes Mellitus
NCT00287651 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Effect of Laser Treatment for Diabetic Retinopathy on the Optic Disc Topography
NCT03476967 ·Status: COMPLETED